reports
Peoples Financial Services Corp: 1 director
A director at Peoples Financial Services Corp sold 5,659 shares at 52.233USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
- Jonathan Moreland
KVHI KVH INDUSTRIES INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
EXAS EXACT SCIENCES CORPORATION
CNC CENTENE CORPORATION
HLNE HAMILTON LANE INCORPORATED CLASS A
SNBR SLEEP NUMBER CORPORATION
GNL GALEY & LORD INC.
ADV ADVANTAGE SOLUTIONS INC (A)
OPCH OPTION CARE HEALTH INC
UAN CVR PARTNERS LP
OSCR OSCAR HEALTH
BGS B&G FOODS
TCBX INC.
VANI THIRD COAST BANCSHARES INC
GRNT VIVANI MEDICAL INC
SES GRANITE RIDGE RESOURCES INC
SES AI CORPORATION
Alto Ingredients Publishes its Annual Sustainability Report
Alto Ingredients Publishes its Annual Sustainability Report PEKIN, Ill., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, published its second Sustainability Report highlighting the company’s 2023 sustainability metrics and accomplishments. “This report underscores our ongoing commitment to sustainability and provides insight into our programs and performance,” stated Alto Ingredients CEO, Bryon McGregor. “Driven by our core values of responsibility, integrity, and...
Alto Ingredients, Inc. Reports Third Quarter 2024 Results
Alto Ingredients, Inc. Reports Third Quarter 2024 Results - Enters CO2 Transportation and Sequestration Agreement with Vault 44.01 - PEKIN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter ended September 30, 2024. In a separate press release, the company announced it entered into a CO2 Transportation and Sequestration Agreement (TSA) with Vault 44.01 to transport, inject and sequester carbon from the company’s ...
Alto Ingredients, Inc. Enters CO2 Transportation and Sequestration Agr...
Alto Ingredients, Inc. Enters CO2 Transportation and Sequestration Agreement with Vault 44.01 PEKIN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it entered into a CO2 Transportation and Sequestration Agreement (TSA) with Vault 44.01 to provide transportation, injection and sequestration into the Mt. Simon sandstone formation in Illinois of CO2 produced at Alto Ingredients’ Pekin campus. “Continually striving to increase opportunities, improve p...
Alto Ingredients, Inc. to Release Third Quarter 2024 Financial Results...
Alto Ingredients, Inc. to Release Third Quarter 2024 Financial Results on November 6, 2024 PEKIN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its third quarter 2024 financial results after the close of market on Wednesday, November 6, 2024. Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time and will deliver prepared remarks via webcast followed by a question-and-answer session. How to parti...
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at...
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024 AUSTIN, Texas, Oct. 30, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that updated analyses of data from the Company’s Phase 2 OraGrowtH210 and OraGrowtH212 clinical trials have been accepted for oral presentation at the , or ESPE 2024, to be held November 16-18, 2024 in Liverpool, UK. Two abstracts on data from the OraGrowtH Trials evaluating oral LUM-201 for Pediatric Growth Hormone Defi...
Lumos Pharma Enters into Definitive Merger Agreement with Double Point...
Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR) Lumos Pharma and the FDA Align on Final Design for Global, Double-blinded, Placebo-Controlled Phase 3 Trial Evaluating Oral LUM-201 in PGHD AUSTIN, Texas, Oct. 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:LUMO) (“Lumos Pharma” or the “Company”), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that the Company has entered into a definitive merger agreement, dated October 2...
Alto’s Magic Valley Facility Production Rate Consistently Achieving Fu...
Alto’s Magic Valley Facility Production Rate Consistently Achieving Full Capacity PEKIN, Ill., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuel and essential ingredients, provided updates on its Magic Valley facility in Idaho where it has installed Harvesting Technology’s patented system to capture its high protein and corn oil products. For October to date, the new equipment and system modifications to improve capacity at the Magic Valley facility are delivering the following metrics: ...
Lumos Pharma Announces Abstract Accepted for Oral Presentation at the ...
Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024 AUSTIN, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an updated analysis of data from its Phase 2 OraGrowtH210 clinical trial has been accepted for presentation at the , or APPES 2024, to be held October 2-5, 2024 in New Delhi, India. This analysis of data from the OraGrowtH210 Trial evaluating oral LUM-201 for...
Lumos Pharma Announces Abstract Accepted for Presentation at September...
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024 AUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an updated analysis of data from its Phase 2 OraGrowtH210 and OraGrowtH212 clinical trials has been accepted for presentation at the (Sociedad Latinoamericana de Endocrinología Pediátrica), or SLEP 2024, to be held September 11-14, 2024 in Santiago, Chile. Abstract Presentation: Friday, September 13th – E-poster Session ...
Alto Ingredients, Inc. to Present in the 26th Annual H.C. Wainwright G...
Alto Ingredients, Inc. to Present in the 26th Annual H.C. Wainwright Global Investment Conference PEKIN, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel, essential ingredients and specialty alcohols, announced that management plans to participate at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024 in New York City. Management will conduct one-on-one meetings, and management will present at 10:00 am ET. Presentation materials and webcast for the presentation can be accessed at ...
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Inve...
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference AUSTIN, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference being held September 9th – 11th in New York City. Lumos Pharma management will be present to host one-on-one meetings on Monday and Tuesday, September 9th and 10th. H.C. Wainwright 26th Annual Global Investment Conference: September 9th – 11th Ti...
- Jonathan Moreland
SAIA SAIA INC.
RHP RYMAN HOSPITALITY PROPERTIES INC.
PBPB POTBELLY CORP.
OEC ORION ENGINEERED CARBONS SA
NEOG NEOGEN CORPORATION
LGND LIGAND PHARMACEUTICALS INCORPORATED
KVHI KVH INDUSTRIES INC.
INTC INTEL CORPORATION
HTGC HERCULES CAPITAL INC.
HRZN HORIZON TECHNOLOGY FINANCE CORP.
FPI FARMLAND PARTNERS REIT
FOXF FOX FACTORY HOLDING CORP.
FFIN FIRST FINANCIAL BANKSHARES INC
EHTH EHEALTH INC.
CRK COMSTOCK RESOURCES INC.
CHCT COMMUNITY HEALTHCARE TRUST INCORPORATED
BXMT BLACKSTONE MORTGAGE TRUST INC. CLASS A
AGCO AGCO CORPORATION
TEX TEREX CORPORATION
MEDP MEDPACE HOLDINGS INC.
ATEC ALPHATEC HOLDINGS INC.
MGM MGM RESORTS INTERNATIONAL
RIGN TRANSOCEAN LTD.
LIND LINDBLAD EXPEDITIONS HOLDINGS
AMBC AMBAC FINANCIAL GROUP INC.
SNBR SLEEP NUMBER CORPORATION
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
DIS THE WALT DISNEY COMPANY
AXR AMREP
VCNX VACCINEX
STRA STRATEGIC EDUCATION INC.
PFIS PEOPLES FINANCIAL SERVICES CORP.
CMTV COMMUNITY BANCORP INC. VT
TSLX SIXTH STREET SPECIALTY LENDING
ONEW INC.
AZYO ONEWATER MARINE
MPLN AZIYO BIOLOGICS
CTOS MULTIPLAN CORP CLASS A
CVRX CUSTOM TRUCK ONE SOURCE
RPID INC.
GLSI CVRX
MBLY INC.
ATMU RAPID MICRO BIOSYSTEMS INC
GT GREENWICH LIFESCIENCES INC
NBBK MOBILEYE GLOBAL INC
MOBQ ATMUS FILTRATION TECHNOLOGIES INC
GOODYEAR TIRE & RUBBER CO.
NB BANCORP INC.
MOBIQUITY TECHNOLOGIES
INC.
- Jonathan Moreland
RHP RYMAN HOSPITALITY PROPERTIES INC.
PBPB POTBELLY CORP.
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
OEC ORION ENGINEERED CARBONS SA
NEOG NEOGEN CORPORATION
INTC INTEL CORPORATION
CRK COMSTOCK RESOURCES INC.
MEDP MEDPACE HOLDINGS INC.
NINE NINE ENERGY SERVICE INC
VCNX VACCINEX
PFIS PEOPLES FINANCIAL SERVICES CORP.
ZM ZOOM VIDEO COMMUNICATIONS
TSLX INC.
MPLN SIXTH STREET SPECIALTY LENDING
GEVO INC.
CTOS MULTIPLAN CORP CLASS A
RPID GEVO
GLSI CUSTOM TRUCK ONE SOURCE
INC.
RAPID MICRO BIOSYSTEMS INC
GREENWICH LIFESCIENCES INC
Alto Ingredients, Inc. Reports Second Quarter 2024 Results
Alto Ingredients, Inc. Reports Second Quarter 2024 Results PEKIN, Ill., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel, essential ingredients and specialty alcohols, reported its financial results for the quarter ended June 30, 2024. Bryon McGregor, President and CEO of Alto Ingredients, said, “Our Pekin Campus has been producing alcohol and serving customers for over 150 years throughout many market cycles. We continue to strengthen our facilities by reinvesting our cash flow from operations and excess liquidity in c...
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
SIGI SELECTIVE INSURANCE GROUP INC.
SAIC SCIENCE APPLICATIONS INTERNATIONAL CORP.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
MXL MAXLINEAR INC
LKQ LKQ CORPORATION
FFIN FIRST FINANCIAL BANKSHARES INC
ACRS ACLARIS THERAPEUTICS INC.
CULP CULP INC.
NAD NUVEEN QUALITY MUNICIPAL INCOM
EVBN EVANS BANCORP INC.
LW LAMB WESTON HOLDINGS INC.
UBFO UNITED SECURITY BANCSHARE
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
ESQ ESQUIRE FINANCIAL HOLDINGS
AXR AMREP
FXNC FIRST NATIONAL CORP. OF VIRGINIA
VCNX VACCINEX
PFIS PEOPLES FINANCIAL SERVICES CORP.
REKR REKOR SYSTEMS
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
FNWB FIRST NORTHWEST BANCORP
AESE ALLIED ESPORTS ENTERTAINMENT
AZYO AZIYO BIOLOGICS
COFS CHOICEONE FINANCIAL SERVICES
TKNO ALPHA TEKNOVA
ADCT INC.
ACHR ADC THERAPEUTICS SA
ABIO ARCHER AVIATION INC
TPST ARCA BIOPHARMA INC
PET MILLENDO THERAPEUTICS
KMPH INC.
BIGZ WAG GROUP CO
DOUG KEMPHARM INC
LCTC BLACKROCK INNOVATION AND GROWTH TST
LUXH DOUGLAS ELLIMAN INC
FCCND LIFELOC TECHNOLOGIES INC
NE LUXURBAN HOTELS INC
STRW SPECTRAL CAPITAL CORP
ASPI NOBLE CORP (NEW)
MIO STRAWBERRY FIELDS REIT INC.
NUZE ASP ISOTOPES INC
BNED PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
DMA NUZEE INC.
MXF BARNES & NOBLE EDUCATION INC.
SSKN DESTRA MULTI ALTERNATIVE FUND
ADVM THE MEXICO FUND
NYC INC.
STRATA SKIN SCIENCES INC.
ADVERUM BIOTECHNOLOGIES INC.
NEW YORK CITY REIT
INC.
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
LPSN LIVEPERSON INC.
BGNE BEIGENE LTD. SPONSORED ADR
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
CLF CLIFFS NATURAL RESOURCES INC.
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
VCNX VACCINEX
ANIX ANIXA BIOSCIENCES
PFIS PEOPLES FINANCIAL SERVICES CORP.
CBNK CAPITAL BANCORP
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
AZYO AZIYO BIOLOGICS
GEVO GEVO
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BYON BEYON 3D LTD
PEO PETROLEUM & RESOURCES CORPORATION
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provide...
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update Following Positive End of Phase 2 Meeting with FDA, Company Continues to Advance Plans for Phase 3 Placebo-Controlled Trial of LUM-201 in Moderate Pediatric Growth Hormone Deficiency Expects to Initiate Phase 3 Trial in Q2 2025 Company to Host Conference Call Today at 4:30PM ET AUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced financial results for the quarter ended June 3...
Alto Ingredients, Inc. to Release Second Quarter 2024 Financial Result...
Alto Ingredients, Inc. to Release Second Quarter 2024 Financial Results on August 6, 2024 PEKIN, Ill., July 30, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel and essential ingredients and the largest producer of specialty alcohols in the United States, announced it will release its second quarter 2024 financial results after the close of market on Tuesday, August 6, 2024. Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time and will deliver prepared remarks via webcast followed by a ques...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.